The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases
Authors
Keywords
Tau protein, Breast cancer, Brain metastases, Tumor markers, Predictive factors, Prognostic factors
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-01-30
DOI
10.1186/s12885-019-5287-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience
- (2018) Gaia Griguolo et al. BREAST
- Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
- (2016) Amélie Darlix et al. BMC CANCER
- Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?
- (2016) Amélie Darlix et al. INTERNATIONAL JOURNAL OF CANCER
- Increased cerebrospinal fluid cleaved tau protein (C-tau) levels suggest axonal damage in pediatric patients with brain tumors
- (2015) Pelin Cengiz et al. CHILDS NERVOUS SYSTEM
- Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases
- (2015) Ishwaria M. Subbiah et al. JOURNAL OF CLINICAL ONCOLOGY
- Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer
- (2015) Yingbo Shao et al. PLoS One
- Biomarker Analyses in CLEOPATRA: A Phase III, Placebo-Controlled Study of Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive, First-Line Metastatic Breast Cancer
- (2014) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Tau, S-100 Calcium-Binding Protein B, and Neuron-Specific Enolase as Biomarkers of Concussion—Reply
- (2014) Pashtun Shahim et al. JAMA Neurology
- An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients
- (2013) A. C. Regierer et al. ANNALS OF ONCOLOGY
- Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers
- (2013) Jun Sang Lee et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome
- (2013) Dorien J. A. Lobbezoo et al. BREAST CANCER RESEARCH AND TREATMENT
- Serum Lactate Dehydrogenase Is Prognostic for Survival in Patients with Bone Metastases from Breast Cancer: A Retrospective Analysis in Bisphosphonate-Treated Patients
- (2012) J. E. Brown et al. CLINICAL CANCER RESEARCH
- Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data
- (2012) Faith G. Davis et al. NEURO-ONCOLOGY
- HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer
- (2011) Chantal Tsé et al. CANCER TREATMENT REVIEWS
- Correlation of Levels of Neuronal and Glial Markers with Radiological Measures of Infarct Volume in Ischaemic Stroke: A Systematic Review
- (2011) Omar Ahmad et al. CEREBROVASCULAR DISEASES
- Predictive and Prognostic Values of Tau and ERCC1 in Advanced Breast Cancer Patients Treated with Paclitaxel and Cisplatin
- (2010) Y. Y. Shao et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
- (2010) David M Rissin et al. NATURE BIOTECHNOLOGY
- Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells
- (2010) M A Matrone et al. ONCOGENE
- Third consensus on medical treatment of metastatic breast cancer
- (2009) S. Beslija et al. ANNALS OF ONCOLOGY
- Microtubule-associated protein tau in human prostate cancer cells: Isoforms, phosphorylation, and interactions
- (2009) Skye Souter et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Prognosis of Women With Metastatic Breast Cancer byHER2Status and Trastuzumab Treatment: An Institutional-Based Review
- (2009) Shaheenah Dawood et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic factors in 1038 women with metastatic breast cancer
- (2008) R. Largillier et al. ANNALS OF ONCOLOGY
- Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients
- (2008) Judith M. de Bont et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Prognostic Factors in Metastatic Breast Cancer: Successes and Challenges Toward Individualized Therapy
- (2008) Eleni Andreopoulou et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started